Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemfibrozil for Nicotine Smoking Cessation
NCT02638597Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2015
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of gemfibrozil in Tobacco Use Disorder (TUD), sponsored by UT Southwestern Medical Center. Started Feb 2015; status: completed.
02
Drugs
gemfibrozil
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02638597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638597.